Targeting intrinsically disordered proteins involved in cancer

Area of Science:

• Biochemistry and Molecular Biology
• Drug Discovery and Development
• Oncology

Background:

• Intrinsically disordered proteins (IDPs) lack stable structures but play vital roles in cellular signaling and regulation.
• Dysregulation of IDPs is implicated in various cancers, making them significant therapeutic targets.
• The inherent flexibility of IDPs presents unique challenges for drug development.

Purpose of the Study:

• To review recent advancements in targeting intrinsically disordered proteins (IDPs) for cancer therapy.
• To explore strategies for developing small molecules that can effectively target IDPs.
• To provide insights into the general principles of targeting IDPs based on cancer-related examples.

Main Methods:

• Summarizing experimental and computational approaches for identifying IDP-targeting molecules.
• Analyzing strategies for small molecule design, including library screening and interface-based design.
• Reviewing case studies of successful IDP targeting in various cancer types.

Main Results:

• Small molecules targeting IDPs have been successfully developed and repurposed for cancer treatment.
• Strategies often involve targeting hydrophobic regions within IDPs to disrupt protein-DNA or protein-protein interactions.
• In most cases, the targeted IDPs retain their disordered state after molecular binding.

Conclusions:

• Targeting IDPs, despite their dynamic nature, is a viable therapeutic strategy for cancer.
• Small molecule design approaches for IDPs share similarities with those for well-folded proteins.
• Further research into IDP targeting can yield broader therapeutic applications beyond cancer.